Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report-Reference-Cited by-同舟云学术

Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report

Published:2022-06 Issue:6 Volume:28 Page:810-813
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Arai Tatsuya^ORCID,Mukai Satoru,Kazama Ryo^ORCID,Ogawa Yoshihiko^ORCID,Nishida Koji,Hatanaka Kazuo,Gohma Iwao

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference15 articles.

1. Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis;Martínez-Calle;Br J Haematol,2019

2. Determinants of outcome in Covid-19 hospitalized patients with lymphoma: a retrospective multicentric cohort study;Lamure;EClinicalMedicine,2020

3. Epidemiologic features and clinical course of patients infected with SARS- CoV-2 in Singapore;Young;JAMA,2020

4. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer;Aydillo;N Engl J Med,2020

5. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient;Nakajima;J Infect Chemother,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study;Viruses;2024-02-21

2. A Teaching Case: Persistent COVID-19 Pneumonia Resembling Cryptogenic Organizing Pneumonia in a Patient With Remitted Lymphoma;Cureus;2023-11-05

3. Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma;Annals of Hematology;2023-04-12

4. Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal Antibodies;Internal Medicine;2022-12-15

5. Prolonged COVID-19 in a Multiple Sclerosis Patient Treated With Rituximab;Cureus;2022-12-14